Robert Rehard
CIK 1632039 · View on SEC EDGAR ↗
First SEC filing: April 5, 2018 · Latest: April 16, 2026
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 25, 2026 | RRX | S | 968 | $223.00 | $215,864 | 34,447 Direct | -2.73% | Disposed | -22.9% (price as of 2026-08-19) |
| Feb. 24, 2026 | RRX | S | 1,289 | $223.13 | $287,615 | 35,415 Direct | -3.51% | Disposed | -23.0% (price as of 2026-08-19) |
| Feb. 9, 2026 | RRX | S | 7,704 | $216.72 | $1,669,611 | 34,154 Direct | -18.41% | Disposed | -20.7% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Nov. 7, 2024 | RRX | Stock Appreciation Rights | Common Stock (3,317) | $54.79 | May 11, 2026 | 3,317 | Disposed |
| Nov. 7, 2024 | RRX | Stock Appreciation Rights | Common Stock (2,148) | $74.56 | May 12, 2025 | 2,148 | Disposed |
| Feb. 23, 2024 | RRX | Stock Appreciation Rights | Common Stock (7,657) | $168.47 | Feb. 23, 2034 | 7,657 | Acquired |
| Feb. 23, 2023 | RRX | Stock Appreciation Rights | Common Stock (9,456) | $154.20 | Feb. 23, 2033 | 9,456 | Acquired |
| Feb. 23, 2022 | RRX | Stock Appreciation Rights | Common Stock (8,292) | $151.27 | Feb. 23, 2032 | 8,292 | Acquired |
| Feb. 23, 2021 | RRX | Stock Appreciation Rights | Common Stock (8,850) | $140.22 | Feb. 23, 2031 | 8,850 | Acquired |
| Feb. 18, 2020 | RRX | Stock Appreciation Rights | Common Stock (11,773) | $88.45 | Feb. 18, 2030 | 11,773 | Acquired |
| May 8, 2019 | RRX | Stock Appreciation Rights | Common Stock (14,675) | $81.81 | May 8, 2029 | 14,675 | Acquired |
| May 9, 2018 | RRX | Stock Appreciation Rights | Common Stock (7,375) | $77.60 | May 9, 2028 | 7,375 | Acquired |
| May 11, 2016 | RRX | Stock Appreciation Rights | Common Stock (3,165) | $57.43 | May 11, 2026 | 3,165 | Acquired |
| May 12, 2015 | RRX | Stock Appreciation Rights | Common Stock (2,050) | $78.15 | May 12, 2025 | 2,050 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 4 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| April 5, 2018 | RRX | Common Stock | 2,919 | Direct |
| April 5, 2018 | RRX | Stock Appreciation Rights→ Common Stock (2,050) | 2,050 | Direct |
| April 5, 2018 | RRX | Stock Appreciation Rights→ Common Stock (3,165) | 3,165 | Direct |
| April 5, 2018 | RRX | Stock Appreciation Rights→ Common Stock (2,065) | 2,065 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
RRX
CFO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $745,306 | — | — | — | $561,613 | — | $181,288 | $3,902,191 |
| 2023 | $655,810 | — | $2,186,543 | $512,515 | $665,537 | — | $153,879 | $4,174,284 |
| 2022 | $603,720 | $0 | $1,139,417 | $350,005 | $510,833 | $0 | $116,614 | $2,720,589 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.